Zhengjun Chen

Title: Innovations and Contributions of Inventor Zhengjun Chen

Introduction

Zhengjun Chen is a notable inventor based in Graefelfing, Germany. He has made significant contributions to the field of molecular biology and biotechnology. With a total of 2 patents, his work focuses on nucleic acids and their applications in diagnosing and treating various conditions.

Latest Patents

Zhengjun Chen's latest patents include innovative methods and compositions related to nucleic acids encoding BDP-1 and other polypeptides. His patents describe nucleic acid molecules that encode full-length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides. These inventions encompass nucleic acid vectors, recombinant cells, and methods for identifying compounds that interact with these polypeptides. Additionally, he has developed methods for diagnosing abnormal conditions in organisms related to these molecules. His work also includes monoclonal antibodies that specifically bind to the extracellular domain of SIRP cell surface glycoproteins, which can block interactions with the surface molecule CD47.

Career Highlights

Zhengjun Chen has worked with prestigious institutions such as the Max Planck Society for the Advancement of Science and the Eberhard Karls University of Tübingen University Hospital. His research has contributed to advancements in understanding the roles of specific proteins in various biological processes.

Collaborations

Throughout his career, Zhengjun Chen has collaborated with esteemed colleagues, including Axel Ullrich and Naohito Aoki. These partnerships have further enhanced the impact of his research in the scientific community.

Conclusion

Zhengjun Chen's innovative work in molecular biology has led to valuable patents that contribute to the understanding and treatment of diseases. His research continues to influence the field and showcases the importance of collaboration in scientific advancements.